38 Stocks Moving In Friday's Mid-Day Session

Gainers

• Vertex Energy, Inc. VTNR shares surged 48.6% to $5.93 on continued momentum after the company announced it will acquire an Alabama refinery and related logistics assets for $75 million. HC Wainwright maintained a Buy rating on the stock and raised its price target from $4 to $25.
• eMagin Corporation EMAN gained 28.8% to $3.425. eMagin, earlier during the month, reported a loss for its first quarter.
• Mannatech, Inc. MTEX rose 24.6% to $24.85 after the company announced intent to commence a cash tender offer to purchase up to 211,538 shares of its common stock at $26 per share.
• Organovo Holdings, Inc. ONVO gained 22.4% to $9.52 following recent Seeking Alpha article 'Organovo: New Strategy Targeting Internal Pipeline Development With Customized 3D Human Tissues Offers Upside.'
• Welbilt, Inc. WBT gained 19.5% to $23.81. Welbilt won a $3.3 billion bid from Italy's Ali Group, Reuters reported citing WSJ.
• Yext, Inc. YEXT rose 18.6% to $14.60 after the company reported better-than-expected Q1 results and issued strong revenue guidance .
• AMC Entertainment Holdings, Inc. AMC shares gained 16.6% to $30.92 on continued momentum amid renewed retail investor interest in the stock.
• MicroVision, Inc. MVIS surged 15% to $18.19.
• Iterum Therapeutics plc ITRM rose 14.6% to $1.41 after the company issued an update on NDA review for sulopenem etzadroxil/probenecid.
• Intevac, Inc. IVAC surged 14.4% to $6.81.
• BlackBerry Limited BB gained 14% to $11.35 amid renewed retail investor interest in the stock.
• Adagene Inc. ADAG surged 13.8% to $14.45.
• Koss Corporation KOSS rose 12.2% to $25.61. Koss shares jumped over 10% on Thursday amid continued speculative retail trading in the name.
• Cricut, Inc. CRCT shares jumped 12.2% to $36.08. Cricut, earlier during the month, posted upbeat quarterly results.
• Freeline Therapeutics Holdings plc FRLN gained 12% to $10.98.
• Veeva Systems Inc VEEV climbed 10.8% to $293.14 after the company reported better-than-expected Q1 results and issued Q2 FY21 guidance above estimates.
• Ollie's Bargain Outlet Holdings Inc OLLI rose 10% to $88.46 after the company reported better-than-expected Q1 results.
• MOGU Inc. MOGU shares rose 7.8% to $1.65 after reporting Q4 results.
• Express, Inc. EXPR rose 6.2% to $5.11 after a 13G filing showed DE Shaw has a 5% stake in the company.
• salesforce.com, inc. CRM rose 6% to $239.20 after the company reported better-than-expected results for its first quarter. The company issued strong forecast for the current quarter and also raised its FY22 guidance.
• Ulta Beauty, Inc. ULTA rose 5% to $344.48 after the company reported better-than-expected Q1 sales and raised FY21 guidance.
• Titan Medical Inc. TMDI surged 4.5% to $1.9110 after the company announced it has received a $10 million license fee upon achievement of a milestone under Medtronic development.
• Afya Limited AFYA gained 4% to $23.58 after the company reported better-than-expected Q1 EPS results.

Check out these big penny stock gainers and losers

Losers

• Orbsat Corp. OSAT shares dipped 74.2% to $4.1150 after the company reported pricing of upsized $14.4 million underwritten public offering and uplisting to Nasdaq.
• 1847 Goedeker Inc. GOED fell 69.5% to $1.8501 after the company priced its 91 million unit offering at $2.25 per unit.
• ZIVO Bioscience, Inc. ZIVO dropped 57% to $4.1292 after the company reported pricing of upsized $13.8 million public offering and uplisting to Nasdaq.
• Moxian, Inc. MOXC dipped 31% to $11.69.
• Provention Bio, Inc. PRVB shares fell 22.6% to $8.26. Provention Bio said the Endocrinologic and Metabolic Drugs Advisory Committee voted 10-7 in favor of the benefits of teplizumab outweighing the risks in support of approval to delay clinical type 1 diabetes mellitus. The PDUFA action date is July 2.
• U.S. Silica Holdings, Inc. SLCA dropped 17.1% to $10.26. Barclays downgraded US Silica from Equal-Weight to Underweight and lowered the price target from $12 to $10.
• Eton Pharmaceuticals, Inc. ETON fell 13.1% to $7.38 after the company received a Complete Response Letter (CRL) from the FDA related to a marketing application for its dehydrated alcohol injection to treat methanol poisoning. The CRL indicated that the FDA has completed its review of the application and has determined that the application cannot be approved in its present form.
• Lannett Company, Inc. LCI dipped 12.3% to $4.3350.
• Caleres, Inc. CAL fell 12% to $24.00 after the company reported Q1 results and issued weak sales forecast for the current quarter.
• Castor Maritime Inc. CTRM dipped 11.2% to $3.185.
• Eos Energy Enterprises, Inc. EOSE fell 11.2% to $18.84 after gaining over 15% on Thursday.
• HP Inc. HPQ fell 9.1% to $29.18. HP reported upbeat results for its fiscal second quarter and raised its FY21 earnings forecast.
• Humanigen, Inc. HGEN dipped 8% to $20.95. Humanigen reported submission of application to the FDA for Emergency Use Authorization of its Lenzilumab for COVID-19.
• Big Lots, Inc. BIG fell 7.6% to $59.64. Big Lots posted upbeat Q1 results.
• Tuniu Corporation TOUR tumbled 6.9% to $2.69. Tuniu is expected to report Q1 results on June 3.